James Oliviero
Vorstandsvorsitzender bei CHECKPOINT THERAPEUTICS, INC.
Vermögen: 3 Mio $ am 30.04.2024
Ursprung des Netzwerks ersten Grades von James Oliviero
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 34 | |
| Public Company | Pharmaceuticals: Major | 9 | |
| Public Company | Pharmaceuticals: Major | 7 | |
ACCESS Oncology, Inc.
 ACCESS Oncology, Inc. Pharmaceuticals: OtherHealth Technology Part of Akebia Therapeutics, Inc., ACCESS Oncology, Inc. is a company that develops pharmaceutical drugs. The company is based in New York, NY. The company was founded by Michael Sean Weiss. ACCESS Oncology was acquired by Keryx Biopharmaceuticals, Inc., part of Akebia Therapeutics, Inc. from December 13, 2018 on February 06, 2004 for $36.44 million.
1
| Subsidiary | Pharmaceuticals: Other | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von James Oliviero
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| MUSTANG BIO, INC. | Pharmaceuticals: Major | Director/Board Member Chairman Director of Finance/CFO Director/Board Member Investor Relations Contact | |
| TG THERAPEUTICS, INC. | Pharmaceuticals: Major | Founder Chief Executive Officer Director/Board Member Director of Finance/CFO Director/Board Member | |
| AVENUE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director of Finance/CFO Director/Board Member Investor Relations Contact | |
| Baruch College | College/University | Undergraduate Degree Undergraduate Degree Masters Business Admin Undergraduate Degree | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Investor Relations Contact Corporate Officer/Principal General Counsel | |
| STEMLINE THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Operating Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| XTL BIOPHARMACEUTICALS LTD. | Medical Specialties | Chairman Chief Executive Officer Director of Finance/CFO | |
| JOURNEY MEDICAL CORPORATION | Pharmaceuticals: Major | Chairman Director/Board Member Investor Relations Contact | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| ORIGO ACQUISITION CORP | Financial Conglomerates | Chief Executive Officer Chairman Director/Board Member | |
| Ithaca College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Opus Point Partners Management LLC
 Opus Point Partners Management LLC Investment ManagersFinance Opus Point Partners Management LLC (OPPM) is a hedge fund manager headquartered in New York City. The firm was founded by Lindsay Rosenwald and Michael Weiss in 2009. They are owned by Opus Point Partners LLC, which is a subsidiary of Weiss & Co. LLC. OPPM manages investments that are dedicated to healthcare and life science. | Investment Managers | Chief Executive Officer Founder Director of Finance/CFO | |
| IRONWOOD PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Sales & Marketing Corporate Officer/Principal | |
| IDENIX PHARMACEUTICALS INC | Pharmaceuticals: Major | Chief Executive Officer Investor Relations Contact | |
KPMG LLP
 KPMG LLP Miscellaneous Commercial ServicesCommercial Services KPMG LLP engages in the provision of audit, tax, and advisory services. It serves the banking and capital markets, building, construction and real estate, consumer and retail, energy, natural resources and chemicals, financial services, government and public sector, healthcare and life sciences, industrial manufacturing, insurance, media and entertainment, private equity, technology, telecommunications, and venture capital industries. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| DYADIC INTERNATIONAL, INC. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| University of Massachusetts | College/University | Undergraduate Degree Undergraduate Degree | |
| Emory University | College/University | Graduate Degree Corporate Officer/Principal | |
Kidney Care Partners
 Kidney Care Partners Medical/Nursing ServicesHealth Services Kidney Care Partners provides healthcare services. It specializes in patient survival, hospitalization and patient experience with care. The company was founded in May 2003 and is headquartered in Washington, DC. | Medical/Nursing Services | Chairman Director/Board Member | |
| UNIQURE N.V. | Biotechnology | Director/Board Member Director/Board Member | |
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Pharmaceuticals: Major | Chief Executive Officer President | |
American Kidney Fund, Inc.
 American Kidney Fund, Inc. Medical/Nursing ServicesHealth Services The American Kidney Fund provides treatment and financial assistance to patients with chronic kidney disease. It also provides assistance with expenses that insurance will not cover, such as transportation to dialysis, medications, special diet, kidney donor expenses, and other treatments. It also conducts specialty programs that help patients afford treatment during emergency travel and recover from natural disasters. The company was founded in 1971, and is headquartered in Rockville, MD. | Medical/Nursing Services | Chairman Director/Board Member | |
| Bar-Ilan University | College/University | Masters Business Admin Graduate Degree | |
| NATIONAL HOLDINGS CORPORATION | Investment Banks/Brokers | Chairman Director/Board Member | |
Baergic Bio, Inc.
 Baergic Bio, Inc. Pharmaceuticals: MajorHealth Technology Baergic Bio, Inc. develops therapeutic drugs for the treatment of central nervous system disorders. It offers oncology, rare diseases, and gene therapy. The company is headquartered in New York, NY. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree Masters Business Admin | |
| FORTRESS BIOTECH, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| University of Michigan | College/University | Undergraduate Degree Undergraduate Degree | |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Helocyte, Inc.
 Helocyte, Inc. Miscellaneous Commercial ServicesCommercial Services Helocyte, Inc. engages in the development and commercialization of immunotherapies for the prevention and treatment of cytomegalovirus or CMV (cancer and infectious disease). It focuses on developing PepVax, a HLA-restricted single antigen peptide vaccine for controlling CMV in allogeneic hematopoietic stem cell transplant recipients and Triplex. The company was founded by Donald J. Diamond in 2015 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Founder Director/Board Member | |
Caelum Biosciences, Inc.
 Caelum Biosciences, Inc. BiotechnologyHealth Technology Caelum Biosciences, Inc. operates as a clinical-stage biotechnology company developing treatments for rare and life-threatening diseases. The company was founded in January 2017 and is headquartered in New York, NY. | Biotechnology | Director/Board Member Director/Board Member | |
Cyprium Therapeutics, Inc.
 Cyprium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Fortress Biotech, Inc., Cyprium Therapeutics, Inc. is an American New York-based company focused on developing novel therapies for the treatment of Menkes disease and related copper metabolism disorders. The company was granted FDA breakthrough therapy, fast track, and rare pediatric disease designations, as well as FDA orphan drug designation for both Cutx-101 and AAV-ATP7A. The European Medicines Agency also granted orphan drug designation to Cyprium. In March 2017, Cyprium entered into a cooperative research and development agreement with the Eunice Kennedy Shriver National Institute of Child Health and Human Development to advance the clinical development of Cutx-101 for the treatment of Menkes disease. In 2023, Cyprium completed the transfer of its proprietary rights and assigned its FDA documents pertaining to Cutx-101 to Sentynl Therapeutics, Inc. Cyprium and NICHD also previously entered into a worldwide, exclusive license agreement to develop and commercialize AAV-ATP7A gene therapy, which is currently in pre-clinical development. The company was founded in 2017 by Michael Sean Weiss, Lindsay Allan Rosenwald, and Lung S. Yam, who has been the CEO since then. | Miscellaneous Commercial Services | Founder Founder | |
| Cellvation, Inc. | Chairman Director/Board Member | ||
The American Institute of Certified Public Accountants
 The American Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services The American Institute of Certified Public Accountants provides vocational education in accounting. The company provides services to the accounting community, regulatory bodies, and other organizations. It also operates in Jersey City, Washington, and Lewisville. It was founded in 1887 and is headquartered in New York City, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| State University of New York at Albany | College/University | Undergraduate Degree Undergraduate Degree | |
| SCINAI IMMUNOTHERAPEUTICS LTD. | Pharmaceuticals: Other | Director of Finance/CFO | |
CFO Direct Ltd.
 CFO Direct Ltd. Miscellaneous Commercial ServicesCommercial Services CFO Direct Ltd. is a financial services company based in Raanana, Israel. CFO Direct offers a full suite of financial services to both publicly and privately held companies seeking to outsource their high-level financial and accounting activities. The Israeli company provides outsourced CFO services, as well as audit and review preparation services for public and private companies. CFO Direct's goal is to increase efficiencies, optimize resources, and create value for their clients. The company was founded by Uri Ben-Or, who has been the CEO since incorporation. | Miscellaneous Commercial Services | Chief Executive Officer | |
The New York Women's Foundation
 The New York Women's Foundation Miscellaneous Commercial ServicesCommercial Services The New York Women's Foundation provides social services. Its services include anti-violence, safety, health, sexual rights & reproductive justice, capacity building for grantee partners and economic security. The company was founded in 1987 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
| TELRAD NETWORKS LTD | Telecommunications Equipment | Director of Finance/CFO | |
| BIOXCEL THERAPEUTICS, INC. | Biotechnology | Corporate Officer/Principal | |
| Connecticut College | College/University | Undergraduate Degree | |
| SOLEGREEN | Alternative Power Generation | Director of Finance/CFO | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin | |
| ALLERGAN PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| KARA THER | Pharmaceuticals: Major | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 41 |
| Israel | 8 |
| Niederlande | 3 |
| Irland | 2 |
Sektoral
| Health Technology | 24 |
| Consumer Services | 12 |
| Commercial Services | 8 |
| Finance | 4 |
| Health Services | 4 |
Operativ
| Director/Board Member | 159 |
| Corporate Officer/Principal | 78 |
| Director of Finance/CFO | 63 |
| Independent Dir/Board Member | 52 |
| Chairman | 48 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Uri Ben-Or | 31 |
| Michael Weiss | 25 |
| Ronald Renaud | 24 |
| Joseph Feczko | 23 |
| Lindsay Rosenwald | 23 |
| Neil Herskowitz | 22 |
| Eric Rose | 21 |
| David J. Horin | 18 |
| Kevin Cameron | 17 |
| BILL Kessler | 16 |
| Wyche Fowler | 15 |
| Ronald Bentsur | 13 |
| Abraham Ceesay | 13 |
| John Butler | 12 |
| Barry Salzman | 11 |
- Börse
- Insiders
- James Oliviero
- Unternehmensverbindungen
